AIV Logo AIV Assistant

 Logo Abbott Laboratories - ABL.DE 115.44 EUR

P/E
35.42
EPS
2.88
Yield
1.62%
P/B
4.51
ROE
14.44
Beta
0.72

115.440 EUR

115.440 EUR

Daily: -0.02%
Key Metrics

P/E: 35.42

EPS: 2.88

Book Value: 22.60

Price to Book: 4.51

Debt/Equity: 37.53

% Insiders: 0.525%

Growth

Revenue Growth: 0.04%

Earnings Growth: -0.05%

Dividend

Dividend Yield: 1.62%

Annual dividends: 2.15 EUR

Ex-Div. Date: July 15, 2025

Payout: 28.92%

5y avg Yield: 1.67%

 Logo About Abbott Laboratories - (ABL.DE)

Country: United States

Sector: Health Care

Website: http://www.abbott.com

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Exchange Ticker
EBS (Ireland) ABT.SW
MIL (Italy) ABT.MI
FRA (Germany) ABL.F
STU (Germany) ABL.SG
BUE (Argentina) ABT.BA
MEX (Mexico) ABT.MX
SGO (Chile) ABT.SN
VIE (Austria) ABT.VI
SGO (Chile) ABTCL.SN
SAO (Brazil) ABTT34.SA
NYQ (United States) ABT
GER (Germany) ABL.DE
Dividend Yield

1.62% (5y avg: 1.67%)

Annual Dividends

2.15 EUR

Next ex. div date

July 15, 2025

Payout Ratio

28.92%

Historical Dividends
Year Total Dividends
2026 1.27 EUR
2025 2.20 EUR
2024 2.15 EUR
2023 2.04 EUR
2022 1.88 EUR
2021 1.80 EUR
2020 1.44 EUR
2019 1.28 EUR
2018 1.12 EUR
2017 1.06 EUR
2016 1.04 EUR
2015 0.96 EUR
2014 0.88 EUR
2013 0.28 EUR

Yearly aggregated dividends

Dividends

Abbott Laboratories
Aug 15, 2025 Upcoming
Dividend
0.51391 EUR
Abbott Laboratories
May 15, 2025 Paid
Dividend
0.5637 EUR
Abbott Laboratories
Feb 14, 2025 Paid
Dividend
0.5638 EUR
Abbott Laboratories
Nov 15, 2024 Paid
Dividend
0.4987 EUR
Abbott Laboratories
Aug 15, 2024 Paid
Dividend
0.55 EUR

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion